145 related articles for article (PubMed ID: 37750044)
1. Successful Anticoagulation With Warfarin After Switching From Rifampin to Rifabutin.
Alnewais ME; Landolfa SL; Bean M; Fermo JD
J Prim Care Community Health; 2023; 14():21501319231197588. PubMed ID: 37750044
[TBL] [Abstract][Full Text] [Related]
2. Difficulties in anticoagulation management during coadministration of warfarin and rifampin.
Lee CR; Thrasher KA
Pharmacotherapy; 2001 Oct; 21(10):1240-6. PubMed ID: 11601670
[TBL] [Abstract][Full Text] [Related]
3. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
Hickey MD; Quan DJ; Chin-Hong PV; Roberts JP
Liver Transpl; 2013 Apr; 19(4):457-61. PubMed ID: 23526600
[TBL] [Abstract][Full Text] [Related]
4. Describing the profile of patients on concurrent rifampin and warfarin therapy in western Kenya: a case series.
Maina MW; Pastakia SD; Manji I; Kirui N; Kirwa C; Karwa R
Drugs R D; 2013 Sep; 13(3):191-7. PubMed ID: 23982688
[TBL] [Abstract][Full Text] [Related]
5. Update on the interaction of rifampin and warfarin.
Kim KY; Epplen K; Foruhari F; Alexandropoulos H
Prog Cardiovasc Nurs; 2007; 22(2):97-100. PubMed ID: 17541320
[TBL] [Abstract][Full Text] [Related]
6. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007545. PubMed ID: 23828580
[TBL] [Abstract][Full Text] [Related]
7. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
8. Experience with rifabutin replacing rifampin in the treatment of tuberculosis.
Horne DJ; Spitters C; Narita M
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1485-9, i. PubMed ID: 22008761
[TBL] [Abstract][Full Text] [Related]
9. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
Goldberg SV; Hanson D; Peloquin CA
Clin Infect Dis; 2003 Aug; 37(4):607-8. PubMed ID: 12905149
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
11. A potential interaction between warfarin and atovaquone.
Hidalgo K; Lyles A; Dean SR
Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
[TBL] [Abstract][Full Text] [Related]
12. Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy.
Naiker S; Connolly C; Wiesner L; Kellerman T; Reddy T; Harries A; McIlleron H; Lienhardt C; Pym A
BMC Pharmacol Toxicol; 2014 Nov; 15():61. PubMed ID: 25406657
[TBL] [Abstract][Full Text] [Related]
13. Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature.
Martins MA; Reis AM; Sales MF; Nobre V; Ribeiro DD; Rocha MO; Ribeiro AL
BMC Pharmacol Toxicol; 2013 May; 14():27. PubMed ID: 23641931
[TBL] [Abstract][Full Text] [Related]
14. Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.
Moon SM; Park HY; Jeong BH; Jeon K; Lee SY; Koh WJ
Antimicrob Agents Chemother; 2015 Jan; 59(1):663-5. PubMed ID: 25313207
[TBL] [Abstract][Full Text] [Related]
15. Update on rifampin, rifabutin, and rifapentine drug interactions.
Baciewicz AM; Chrisman CR; Finch CK; Self TH
Curr Med Res Opin; 2013 Jan; 29(1):1-12. PubMed ID: 23136913
[TBL] [Abstract][Full Text] [Related]
16. Inability to attain oral anticoagulation: warfarin-rifampin interaction revisited.
Casner PR
South Med J; 1996 Dec; 89(12):1200-3. PubMed ID: 8969357
[TBL] [Abstract][Full Text] [Related]
17. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
Vernon A; Burman W; Benator D; Khan A; Bozeman L
Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
[TBL] [Abstract][Full Text] [Related]
18. Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model.
Klemens SP; Grossi MA; Cynamon MH
Antimicrob Agents Chemother; 1994 Oct; 38(10):2245-8. PubMed ID: 7840552
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of drug-drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management.
MacDougall C; Canonica T; Keh C; P Phan BA; Louie J
Pharmacotherapy; 2022 Apr; 42(4):343-361. PubMed ID: 35152432
[TBL] [Abstract][Full Text] [Related]
20. Acute Pulmonary Embolism in Emergency Department Patients Despite Therapeutic Anticoagulation.
Liu MY; Ballard DW; Huang J; Rauchwerger AS; Reed ME; Bouvet SC; Vinson DR
West J Emerg Med; 2018 May; 19(3):510-516. PubMed ID: 29760849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
